Coronavirus impact: 29 April - surging profits and depression era declines
29/04/2020 · Alphabet (GOOGL) · Anpario PLC (ANP) · AstraZeneca (AZN) · Diaceutics PLC (DXRX) · EKF Diagnostics Holdings (EKF) · Fevertree Drinks PLC (FEVR) · Next (NXT) · Novacyt SA (NCYT) · NWF Group (NWF) · Persimmon (PSN)
AIM AIM Inheritance Tax potential Coronavirus Dividends UK US
One of the world’s largest companies issued impressive results but the outlook is significantly more challenging. There was also some financial guidance at last from a small diagnostic group whose Covid-19 tests are in strong demand. Our latest update reveals more winners and losers from the current crisis
Alphabet: fabulous quarter but..
Fundamental Asset Management
Buy any of our portfolios with our associates.
Previous article Next article
For access to the top news and insights from the investment world
REGISTER FREEBecome a Champion Investor for just £90 a year.
More on Alphabet
Investing in electric vehicles and autonomous cars
The electric vehicle revolution is, as it were, gathering steam. The car in front will soon…
Ultimate Stocks: no stopping our high-performers
Despite its key assets being out of action for most of the year, the shares of…
More on Anpario PLC
Coronavirus impact: 9 Sept - a day of concrete results
Plenty of results and plenty of positives from AIM companies to encourage
Coronavirus impact: 25 June - cycling is having a great lockdown as this company demonstrates
Cycling and video gaming are at opposite ends of the leisure spectrum, but both have benefited…
More on AstraZeneca
AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?
The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…
Coronavirus impact: 29 April - surging profits and depression era declines
One of the world’s largest companies issued impressive results but the outlook is significantly more challenging.…
More on Diaceutics PLC
An exciting play on the growing market of diagnostic data analytics
This company’s growing data lake of clinical testing data is helping big pharma improve patient testing,…
Coronavirus impact: 7 Sept - seaweed secures the dosh
News today from AIM includes the award of a significant grant to support investigation into the…
More on EKF Diagnostics Holdings
Why bother with an update!
There are a broad range of trading updates covered here, but we can’t understand why one company bothered, when…
Coronavirus impact: 9 Nov – a renewable energy day
Two pioneering companies supporting the renewable energy arena announced positive developments for their rapidly developing technologies.
More on Fevertree Drinks PLC
Positive updates from AIM
Another big day of results and updates, with plenty to encourage investors in AIM
Coronavirus impact: 8 Sept - fabulous results from this AIM blue chip and much more
There were a large number of announcements today, including fabulous results from a fast growing provider of…
More on Next
Are Next and Burberry ready for the new retail normal?
Like many traditional retailers Next and Burberry have both been severely disrupted by lockdown measures caused by…
Coronavirus impact: 29 July - a lesson in excellent financial reporting
The latest report from Next provides a lesson in comprehensive reporting, if only others would follow their lead
More on Novacyt SA
Investing success and new assays
After a volatile start to 2021, the share price of last year’s top AIM performer received…
Novacyt: on these numbers, the cheapest stock on the market
AIM’s top performer from 2020 announces fabulous numbers, but that was last year, what of the…
More on NWF Group
5 small cap dividend stocks for yield and growth
Is it possible to generate an attractive, growing income from small-cap shares? We have found some…
Coronavirus impact: 4 Aug – quality small caps going cheap
Several smaller companies featured here look cracking value, with the reassurance of plenty of cash
More on Persimmon
Income Boosters: Does our dividend portfolio need a housebuilder?
Housebuilders have become income favourites in recent years, but our income portfolio doesn't have any exposure…
Coronavirus impact: 29 April - surging profits and depression era declines
One of the world’s largest companies issued impressive results but the outlook is significantly more challenging.…
